Krystal Biotech, Inc. (KRYS)

NASDAQ

$325.20

$+4.30

(+1.34%)

Regular Market

Krystal Biotech, Inc. (KRYS) Live Price Chart

Last updated: ⁦2026-10-14 15:38:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Krystal Biotech, Inc. (KRYS) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $325.20, with a market capitalisation of $9.83B and a P/E ratio of 39.37. Over the past 52 weeks, its price has ranged from $181.44 to $382.54. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$9.83B
Open	$320.41
Day's High	$382.54
Day's Low	$8.03
Previous Close	$321.16
Volume	59.72K
Average Volume	371.78K
P/E Ratio	39.37
52-Week High	$382.54
52-Week Low	$181.44
Dividend Yield	--
Earnings Date	--

Krystal Biotech, Inc. (KRYS) Stock Price Today

Krystal Biotech, Inc. (KRYS) is currently trading at $325.20 as of 2026-10-14 15:37:00, up 1.26% ($4.03) from the previous close of $321.16

During today's regular trading session, KRYS has traded between $8.03 and $382.54, with a trading volume of 59.72K shares. The current price is near the upper end of today's range.

Krystal Biotech, Inc. (KRYS) 7-Day Stock Price Change

Over the past seven days, Krystal Biotech, Inc. (KRYS) moved from $334.85 to $325.20, representing a decline of 2.88% ($9.66).

The stock traded between $316.86 and $339.69 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 280.25 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

KRYS 52-Week Price Position

Position in Range: 71.5%

52W Low$181.44

52W High$382.54

KRYS is currently trading at $325.20, placing it 71.5% of the way from its 52-week low of $181.44 to its 52-week high of $382.54. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Krystal Biotech, Inc. (KRYS)?

Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.

Krystal Biotech, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	295
Exchange	NASDAQ
Company Website	https://www.krystalbio.com

How to Buy Krystal Biotech, Inc. (KRYS) Stock on MEXC

Eligible investors can buy real shares of Krystal Biotech, Inc. (KRYS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for KRYS and Place Your Order

Open the RealStocks trading page and search for KRYS. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Krystal Biotech, Inc. (KRYS) stock price today?

Krystal Biotech, Inc. (KRYS) is currently trading at $ 325.20, up 1.26% ($4.03) from the previous close of $ 321.16. Intraday prices update in real time during regular trading hours.

2.Is KRYS stock going up or down today?

As of 2026-10-14 15:37:00, KRYS is trading at $ 325.20, up 1.26% ($4.03) from its previous close of $ 321.16. The stock has traded between $ 8.03 and $ 382.54 during today’s regular session. Past price movements do not guarantee future results.

3.What is KRYS pre-market price?

As of 2026-10-14 15:37:00, KRYS is trading at $ 322.52 in pre-market trading, up 0.42% ($1.35) from the previous close of $ 321.16. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is KRYS after-hours price?

As of 2026-10-14 15:37:00, KRYS is trading at $ 323.55 in after-hours trading, up 0.74% ($2.39) from the regular-session close of $ 321.16. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is KRYS stock trading now?

KRYS trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does KRYS sit relative to its 52-week high and low?

Over the past 52 weeks, KRYS has traded between a low of $ 181.44 and a high of $ 382.54. At $ 325.20, the stock is positioned 71.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Krystal Biotech, Inc. in?

Krystal Biotech, Inc. (KRYS) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Krystal Biotech, Inc.'s market capitalisation and where is it listed?

Krystal Biotech, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 9.83B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is KRYS valued in terms of P/E ratio and EPS?

KRYS trades at a P/E ratio of 39.37, based on trailing-twelve-month EPS of $ 8.16. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Krystal Biotech, Inc. pay a dividend?

Krystal Biotech, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.